Advances in familial hypercholesterolemia.

Advances in clinical chemistry Pub Date : 2024-01-01 Epub Date: 2024-03-06 DOI:10.1016/bs.acc.2024.02.004
Martine Paquette, Alexis Baass
{"title":"Advances in familial hypercholesterolemia.","authors":"Martine Paquette, Alexis Baass","doi":"10.1016/bs.acc.2024.02.004","DOIUrl":null,"url":null,"abstract":"<p><p>Familial hypercholesterolemia (FH), a semi-dominant genetic disease affecting more than 25 million people worldwide, is associated with severe hypercholesterolemia and premature atherosclerotic cardiovascular disease. Over the last decade, advances in data analysis, screening, diagnosis and cardiovascular risk stratification has significantly improved our ability to deliver precision medicine for these patients. Furthermore, recent updates on guideline recommendations and new therapeutic approaches have also proven to be highly beneficial. It is anticipated that both ongoing and upcoming clinical trials will offer further insights for the care and treatment of FH patients.</p>","PeriodicalId":101297,"journal":{"name":"Advances in clinical chemistry","volume":"119 ","pages":"167-201"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in clinical chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/bs.acc.2024.02.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/6 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Familial hypercholesterolemia (FH), a semi-dominant genetic disease affecting more than 25 million people worldwide, is associated with severe hypercholesterolemia and premature atherosclerotic cardiovascular disease. Over the last decade, advances in data analysis, screening, diagnosis and cardiovascular risk stratification has significantly improved our ability to deliver precision medicine for these patients. Furthermore, recent updates on guideline recommendations and new therapeutic approaches have also proven to be highly beneficial. It is anticipated that both ongoing and upcoming clinical trials will offer further insights for the care and treatment of FH patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
家族性高胆固醇血症的研究进展。
家族性高胆固醇血症(FH)是一种半显性遗传疾病,影响着全球超过 2500 万人,与严重的高胆固醇血症和过早的动脉粥样硬化性心血管疾病相关。过去十年间,数据分析、筛查、诊断和心血管风险分层方面的进步大大提高了我们为这些患者提供精准医疗的能力。此外,最近更新的指南建议和新的治疗方法也被证明是非常有益的。预计正在进行和即将进行的临床试验将为 FH 患者的护理和治疗提供更多启示。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Natriuretic peptide testing strategies in heart failure: A 2023 update. Advances in endotoxin analysis. Defining allowable total error limits in the clinical laboratory. Gastrointestinal hormones: History, biology, and measurement. Molecular biology of SARS-CoV-2 and techniques of diagnosis and surveillance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1